The paper proceeds as follows. Section two below discusses the topic of protein crystallization in biomedical research as well as our current understanding regarding the contribution of microgravity in developing better quality crystals. Section three addresses possible policy intervention, also including the introduction of a government funded consortium to diffuse risk. Section four outlines a specific model that has recently been developed by RTI International, which provides an interesting quantitative framework for measuring private sector costs. The outcome of this section is essentially a list of needed data and data sources. Finally, Section five concludes.
Research Containing: CASIS
This paper will explore the opportunities and challenges in developing the commercial market in LEO through the ISS program and all its facets, including operations, mission support activities, utilization, and contracting. The role of NASA-funded research in the vertical translation of basic research in space to practical application in the market or to other government service agencies will also be addressed. Other aspects, including government regulation, investment and tax incentives, and possible roles of various government agencies will also be explored. Of particular importance, the role of private industry, currently in the supply business, in the development of the demand for LEO capabilities and services beyond the federal government will be highlighted. In conclusion, this paper will address the prospects in reaching the goal of commercializing LEO starting from where we are today in human spaceflight and the International Space Station.